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Abstract
Children with fragile X syndrome (FXS) face high risk for anxiety disorders, yet no studies have
explored FXS as a high-risk sample for investigating early manifestations of anxiety outcomes.
Negative affect is one of the most salient predictors of problem behaviors and has been associated
with both anxiety and autistic outcomes in clinical and non-clinical pediatric samples. In light of
the high comorbidity between autism and anxiety within FXS, the present study investigates the
relationship between longitudinal trajectories of negative affect (between 8 and 71 months) and
severity of anxiety and autistic outcomes in young males with FXS (n= 25). Multilevel models
indicated associations between elevated anxiety and higher fear and sadness, lower soothability,
and steeper longitudinal increases in approach. Autistic outcomes were unrelated to negative
affect. These findings suggest early negative affect differentially predicts anxiety, not autistic
symptoms, within FXS. Future research is warranted to determine the specificity of the
relationship between negative affect and anxiety, as well as to explore potential moderators.
Characterizing the relationship between early negative affect and anxiety within FXS may inform
etiology and treatment considerations specific to children with FXS, as well as lend insight into
precursors of anxiety disorders in other clinical groups and community samples.
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Anxiety disorders constitute the most commonly diagnosed psychological condition in the
United States, affecting approximately 25 % of individuals during their lifetime (Kessler et
al. 1994) and 2–13 % of children (Costello et al. 2003; Shaffer et al. 1996). Anxiety
disorders are associated with both genetic and environmental vulnerabilities and have been
attributed to disruptions in the emotion-regulating and executive regions of the brain (see
Martin et al. 2010, for review). Several clinical subgroups face higher risk for anxiety
outcomes, including children with neurodevelopmental disorders such as fragile X syndrome
(FXS). Fragile X syndrome is the most common heritable form of intellectual disability,
affecting approximately 1:4000 individuals (Crawford et al. 2001, 2002). The FXS
phenotype is caused by a CGG triplet expansion on the X chromosome (>200 repeats),
which reduces FMR1 protein (FMRP) production and negatively impacts brain function
(Bassell and Warren 2008). Children with FXS demonstrate a constellation of symptoms
including heightened emotional and physiological reactivity, sensory issues, aggression,
social avoidance and withdrawal, stereotypical behavior, impulsivity, and hyperactivity (e.g.
Hall et al. 2008; Hatton et al. 2009; Roberts et al. 2009b).
In light of this broad spectrum of FXS symptoms, it is unsurprising that many children with
FXS are affected by multiple co-occurring conditions that impair learning opportunities and
challenge daily functioning (Bailey et al. 2008a). Anxiety disorders and autism represent
two of the most common and devastating comorbid conditions in individuals with FXS, with
70–83 % experiencing anxiety disorders (Bailey et al. 2008a; Cordeiro et al. 2011) and 25–
60 % meeting diagnostic criteria for autism (Bailey et al. 2008c; Kaufmann et al. 2004).
Although anxiety and autism are highly prevalent and problematic in FXS, their emergence
and co-occurrence in children with FXS are unclear. Prospectively studying the precursors
and manifestation of anxiety and autism in FXS offers valuable insight into precursors of
these disorders in the general population, as well as informs etiology and treatment
considerations specific to children with FXS. The present study longitudinally investigates
the relationship between one salient indicator of psychopathology, early negative affect, and
anxiety and autistic outcomes in young males with FXS.
Anxiety in FXS
Measuring anxiety in FXS is complicated by the cognitive and verbal challenges common to
the phenotype (Boyle and Kaufmann 2010). As such, researchers often rely on parent report
to assess anxiety symptoms. Parents have associated anxiety in children with FXS with
increased arguing, distractibility, and sleeping problems (Sullivan et al. 2007; n= 43, ages 6–
14 years). Data from a national parent survey indicate 70 % of males and 56 % of females
with FXS have received anxiety diagnoses or treatments (Bailey et al. 2008a). The most
common cluster of problem behaviors in males included anxiety in conjunction with
developmental delay, attention problems, and hyperactivity. Notably, within the subset of
males with FXS without developmental delay, 68 % reported high anxiety, indicating
anxiety is not restricted to individuals with FXS and intellectual disability.
In the first study to examine prevalence of anxiety disorders in FXS using Diagnostic and
Statistical Manual criteria (DSM-IV-TR; American Psychiatric Association 2000), Cordeiro
et al. (2011) found 83 % of participants (n=97, ages 5.5–33.3 years) met criteria for any
anxiety disorder, and 58 % exhibited multiple anxiety disorders. Symptoms were measured
using the Anxiety Disorder Interview Schedule for the DSM-IV: Parent Report Version
(ADIS-IV; Silverman and Albano 2004), a semi-structured parent interview. The examiners
considered age and the presence of intellectual disabilities when determining diagnoses.
Consistent with DSM-IV guidelines, adults functioning at the developmental level of a child
were permitted to meet anxiety criteria based on symptoms typically exhibited by children.
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For example, these adults were not required to be described by their parents as recognizing
fears as unreasonable or excessive, and they could express specific phobias by crying,
tantruming, clinging or freezing. The authors validated the ADIS-IV by demonstrating
correspondence with the anxiety subscales of the Anxiety Depression and Mood Scale
(Esbensen et al. 2003), a psychiatric screening tool for individuals with intellectual
disability. The presence of anxiety disorders in FXS was significantly higher than in
comparison groups with nonspecific intellectual disabilities (11 %), Williams Syndrome (62
%) and the general population (10 %). The most common anxiety diagnoses within the FXS
group included specific phobia (60 %), social phobia (58 %), selective mutism (25 %),
generalized anxiety disorder (24 %) and obsessive compulsive disorder (24 %). Social
phobia and post-traumatic stress disorder were more common in individuals over age 18,
consistent with findings in the general population (Kessler et al. 2007). Gender and autism
status were not associated with consistent patterns of anxiety diagnoses, although
individuals with autism were somewhat more likely to exhibit selective mutism, specific
phobias, and social phobia.
The presentation of anxiety in FXS is consistent with behavioral and neurobiological models
of anxiety in non-FXS samples. Mood and anxiety disorders are most commonly attributed
to dysregulation of limbic system in regions such as the hippocampus and amygdala, which
function to modulate stress response and process emotional stimuli, respectively (see Martin
et al. 2010, for review). Repetitive and poorly-modulated activation of stress response
systems results in compromised capacity to adaptively respond to acute challenges
(McEwen 1998), which may be particularly debilitating to children during key periods of
early development (Duke 2008). These neurobiological processes relate to a variety of
biobehavioral symptoms. For example, Barlow (1988, 2000) characterizes anxiety as an
integrated cognitive-affective construct that involves complex, cyclical interactions among
environmental cues, negative affect, attention, arousal modulation, hypervigilence, and
dysfunctional behavior. Consistent with this theoretical framework, avoidant behaviors in
FXS have been linked to physiological dysregulation and hyperarousal (Hall et al. 2009;
Hessl et al. 2002; Roberts et al. 2001), and several studies have reported structural and
functional limbic system differences in FXS (see Hessl et al. 2004, for review). Thus,
although cognitive components of anxiety may present differently in FXS compared to non-
FXS samples, examining the FXS phenotype in light of these neurobiological models may
contribute to our understanding of the multifaceted underpinnings of anxiety.
Autism in FXS
In addition to the high proportion of anxiety disorders in FXS, up to 90 % of individuals
with FXS display autistic symptoms, and 25–60 % meet full autism diagnostic criteria
(Bailey et al. 2008c; Kaufmann et al. 2004). Autism spectrum disorder is a
neurodevelopmental disability that affects approximately 1:54 males in the United States
(Center for Disease Control 2012). Three primary domains of autism symptoms include
social problems, repetitive behaviors or restricted interests, and impaired language; with the
manifestation of these symptoms varying across individuals (American Psychiatric
Association 2000). Similar to elevated rates of anxiety in FXS, approximately 25–49 % of
children and adolescents with idiopathic autism (non-FXS) meet anxiety disorder criteria
(see White et al. 2009, for review). Within FXS, comorbid autism is associated with
increased behavior problems (Hatton et al. 2002), lower adaptive behavior (Hatton et al.
2003; Kau et al. 2004; Rogers et al., 2001), receptive language delays (Rogers et al. 2001),
withdrawal (Kau et al., Kaufmann et al. 2004; Roberts et al. 2007), social indifference
(Budimirovic et al. 2006), and more severely impaired cognitive profiles (Bailey et al.
2001).
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Despite the high prevalence of autistic symptoms in FXS, researchers have debated the
utility and appropriateness of differentially diagnosing children with FXS+autism given the
broad spectrum of socio-communicative and repetitive behavior deficits associated with
FXS without autism. For example, Hall et al. (2010) suggest diagnostic instruments often
produce inconsistent results in FXS, perhaps due to the high prevalence and wide spectrum
of autistic behavioral symptoms present in this population. The neurobiological
underpinnings of autistic symptoms may also differ in FXS and non-FXS samples, as
children with FXS+autism and idiopathic autism have shown differing patterns of brain
volumetrics, particularly in areas related to social cognition (Hazlett et al. 2009: Hoeft et al.
2011). Despite these potential differences, other researchers have advocated for differential
diagnosis of FXS+autism as an accurate and efficacious mechanism for describing
symptoms and organizing treatment. Budimirovic and Kaufmann (2011) propose autism
within FXS presents distinct behavioral, neural, and potential molecular profiles, justifying a
dual diagnosis. Findings from this group suggest the co-occurrence of autism in young
children with FXS can be distinguished by impaired peer relationships and adaptive
socialization (Hernandez et al. 2009), whereas other researchers with older samples have
emphasized atypicalities in communication and repetitive behavior domains (McDuffie et al.
2010). Clarifying the early presentation of autistic symptoms in FXS, particularly in relation
to cognitive abilities, may facilitate stronger conceptualization of this growing and important
area of research.
Distinguishing Anxiety and Autism in FXS
Symptoms of anxiety and autism overlap and interrelate within FXS, although the disorders
have been distinguished through behavioral and physiological profiles. Kaufmann,
Budimirovic and colleagues have published a series of papers characterizing anxiety and
autism as distinct social interaction disorders in FXS (e.g. Budimirovic et al. 2006;
Budimirovic and Kaufmann 2011). The authors propose that social anxiety emerges from a
combination of lower non-verbal abilities and moderate social withdrawal, whereas autism
(either alone or in conjunction with social anxiety) is characterized by a more complex
constellation of severe social withdrawal and lower adaptive socialization or verbal skills.
The authors attribute the emergence of autism in FXS to two neurobiological vulnerabilities:
(1) abnormal cortical development resulting in delayed communicative and attention
processes, and (2) limbic dysfunction resulting in avoidant behavior (Budimirovic et al.
2006). Although anxiety may contribute to the intensification of self-regulatory symptoms
such as hand-flapping or social avoidance, the rates of anxiety disorders in FXS appear
relatively similar across individuals with and without autism. In one of the few studies to
specifically compare anxiety symptoms in FXS versus FXS+autism, Cordeiro et al. (2011)
found that individuals with FXS+ autism did not demonstrate consistent patterns of anxiety
diagnoses, although they were somewhat more likely to exhibit selective mutism, specific
phobias, and social phobia than participants without autism. This inconsistent relationship
between anxiety disorders and autism in FXS underscores the importance of considering the
unique impact and manifestation of each disorder within FXS.
Behavioral and physiological studies have further clarified withdrawal profiles of children
with FXS versus FXS+autism. Roberts et al. (2007) found that children with FXS and low
levels of autistic symptoms showed improved social approach behaviors, particularly eye
contact, as time spent with an unfamiliar person increased, whereas children with FXS and
elevated autistic symptoms maintained social avoidance during the interaction. Roberts et al.
(2009b) later replicated these results and found that elevated baseline levels and blunted
change in cortisol across time predicted increased autistic symptoms in children with FXS
+autism. Several additional studies have documented associations between atypical
physiological arousal and autistic-like symptoms, such as eye contact, within FXS (Hall et
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al. 2008; Hessl et al. 2006). These findings suggest that although autism may present
similarly to anxiety in initial approach behaviors, FXS+autism is associated with a more
severe and consistent patterns of social withdrawal, which may be related to poor
modulation of physiological arousal.
Negative Affect
The complicated co-occurrence of anxiety and autism in FXS warrants investigation into the
early manifestation and predictors of differential psychopathology outcomes in this
population. Negative affect is one of the most commonly studied predictors of problem
behaviors in non-clinical (e.g., Calkins et al. 2007; Lemery et al. 2002) and clinical (e.g.
Hutman et al. 2010) populations. Negative affect is composed of several specific dimensions
of temperament; including fear, approach, soothability, sadness, anger, discomfort, and
motor activity (Putnam et al. 2008). Within typical development, negative affect can
represent an adaptive or appropriate response to environmental challenges. However, both
under- or over-regulation of negative affect are associated with poor outcomes such as
anxiety, depression, and externalizing disorders (Chaplin et al. 2005). Recent research
suggests genetic underpinnings for negative affect in infancy, endorsing the endogenous
nature of negative affect and the potential predictive power of this construct (Holmboe et al.
2010; Sheese et al. 2009).
Early negative affect has been linked to anxiety outcomes through several prospective,
longitudinal studies. Gartstein et al. (2010) found that both initial levels of fear at 4 months,
as well as increases in infant fearfulness over time, predicted anxiety symptoms in typically
developing toddlers. Similarly, Putnam and Stifter (2005) identified a relationship between
infant inhibition and later internalizing symptoms, as well as between infant extraversion
and later externalizing symptoms. Using a large, nationally representative sample
(n=768,600), Grant et al. (2009) found that fussiness at ages 2–3 years prospectively
predicted anxiety at ages 6–7, and poor adaptability predicted anxiety at ages 8–9. However,
neither fussiness nor adaptability predicted anxiety outcomes at ages 10–11, which the
authors attribute to environmental factors that may moderate anxiety outcomes at older ages.
Negative Affect in FXS
Several studies have examined parent-reported negative affect in children with FXS
compared to typical and clinical samples. Levels of temperament have been shown to
remain relatively stable in FXS across early childhood (Hatton, et al.). Compared to typical
controls, parents have indicated elevated activity and withdrawal; as well as lower intensity,
approachability, adaptability, sadness, anger, and persistence in young boys with FXS
(Bailey et al. 2000; Hatton et al. 1999; Roberts et al. 2006; Shanahan et al. 2008). Evidence
suggests that temperament does not differ across participants FXS+autism and FXS-only
(Bailey et al. 2000); however, dampened facial sadness has been associated with autistic
symptoms in FXS (Shanahan et al.). Compared to children with developmental delay, young
children with FXS (n=41, ages 3–6 years) exhibit higher avoidance behavior, lower
withdrawal behavior, and higher positive mood (Kau et al. 2000). No studies have
longitudinally examined whether these early patterns of temperament, negative affect in
particular, relate to later anxiety or autistic outcomes. Furthermore, although levels of
negative affect have been compared across disorders, it is unclear whether levels of negative
affect within the population of children with FXS predict problem behaviors.
Characterizing the relationship between negative affect and psychopathology in FXS is
particularly warranted in light of the growing literature examining similar patterns in high
risk infant siblings of children with autism. Similar to infants with FXS, “infant siblings”
face higher rates of autism diagnoses (10–61 %; Brian et al. 2008; Landa and Garrett-Mayer
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2006; Ozonoff et al. 2011; Yoder et al. 2009) than the general population. Infant and toddler
siblings later diagnosed with autism have shown increased negative affect, irritability, and
object fixation; as well as decreased positive affect, soothability, social engagement, and
cognitive abilities (Bryson et al. 2007; Garon et al. 2009; Zwaigenbaum et al. 2005). Despite
individual differences, the broader infant sibling literature generally endorses negative
affectivity as one of many early indicators associated with autism, warranting examination
of whether similar trends are present in young children with FXS.
Predicting Anxiety and Autism in FXS
Understanding the emergence of anxiety and autism in children with FXS bears important
implications for promoting early, targeted, and effective interventions for affected children
and their families. However, as demonstrated by the high degree of overlap among
symptoms associated with FXS, autism, and anxiety, understanding the specificity of early
indicators to outcomes is an essential first step to informing the emergence of specific
symptoms in FXS. No published studies have prospectively examined the emergence of
anxiety in FXS, and few have prospectively surveyed the emergence of autistic symptoms in
young children with FXS (see Roberts et al. 2011, for exception). This work is particularly
important given the possibility that neurobiological underpinnings of autistic symptoms and
anxiety may differ in FXS and non-FXS samples. As a first step to addressing this important
question, the present study aims to prospectively examine the relationship between early
negative affect and both (1) anxiety and (2) autistic outcomes in young males with FXS.
Based on the documented relationship between negative affect and both anxiety (e.g.
Gartstein et al. 2010; Putnam and Stifter 2005) and autism (e.g. Zwaigenbaum et al. 2005) in
non-FXS samples, we hypothesized that elevated mean levels of negative affect, as well as




Data were drawn from two consecutive longitudinal studies focused on the early
development of FXS, which used similar methods and overlapping samples. The initial
study focused on infants and included 13 males with FXS assessed at 9, 12, 18, and 24
months of age. The subsequent study focused on preschool development and included 45
males with FXS assessed at 18 month intervals, beginning between 12 and 40 months of
age. Our current study includes participants from either study who had at least 2 assessments
and complete data, resulting in 25 boys assessed on negative affect measures between 2 and
7 times (average 4.2). The average age of first assessment was 15.2 months (range 8–35;
SD=6.88). Descriptive statistics are listed in Table 1.
Measures
Negative Affect—We measured negative affect using the Rothbart Temperament scales,
which include the Infant Behavior Questionnaire (IBQ, 3 to 12 months; Rothbart 1981),
Toddler Behavior Assessment Questionnaire- Revised (TBAQ-R, 16 to 35 months;
Goldsmith 1996; Rothbart et al. 2003), and Children’s Behavior Questionnaire (CBQ, 3 to 7
years; Rothbart et al. 2001). Mothers completed the scale corresponding to their child’s
current age at each assessment (range 8–71 months). Each questionnaire includes multiple
items asking parents to rate recent frequency of temperament characteristics using a seven-
point scale.
The present study focuses on four subscales that consistently load on the Negative Affect
domain of temperament and demonstrate continuity across each scale: Fear, Anger/
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Frustration, Sadness, and Soothability (Putnam et al. 2008). We also examined participants’
scores on the Approach scale, which loads on the Surgency temperament domain, due to the
relationship between atypical social approach and autistic symptoms in FXS (Roberts et al.
2009a, b). The Rothbart Scales demonstrate appropriate convergent validity, discriminant
validity, and continuity of temperament dimensions over time (Putnam et al. 2008). Notably,
Putnam and colleagues explicitly state that traits across scales “can be meaningfully
combined… utilizing growth-curve analyses to examine influences maintaining and lawfully
altering longitudinal stability” (p. 402).
Autism Symptom Severity—Autistic outcomes were measured using the Childhood
Autism Rating Scale (CARS; Schopler et al. 1998), an examiner rating scale of autistic
behavior. The CARS demonstrates internal consistency ratings of 0.94 and highly correlates
with clinical ratings of autism (range= 0.80 to 0.88; Schopler et al. 1998) and standardized
instruments including the Autism Diagnostic Interview-Revised (Rutter et al. 2003;
Pilowsky et al. 1998). The CARS has been commonly used with children with FXS (e.g.
Bailey et al. 2001; Hatton et al. 2002; Hatton et al. 2006; Shanahan et al. 2008). The
measure includes 15 items (rated 1 to 4) that measure a range of autistic behaviors. Total
scores above 30 indicate mild to severe autistic behavior. Consistent with administration
guidelines, the CARS was completed after each research assessment using clinical
consensus between at least two examiners. All examiners were trained in CARS
administration by reading the manual, reviewing videotaped vignettes of behavior, and
practicing CARS scoring. Training was overseen by a master rater who had a Ph.D. and
extensive experience with early development in FXS. Each research assessment lasted
approximately 5 hours and included substantial opportunities for both structured and
unstructured interactions between examiners and the participant. Because examiners
maintained unique roles working with the parent or child and were therefore likely to
observe different behaviors throughout the assessment, both examiners provided input on
each item prior to consensus scoring.
Although multiple CARS scores were available for the majority of participants, we selected
each child’s earliest score obtained after 35 months of age (range 35–72 months) to use as
an outcome in the present study, as current DSM-IV criteria require symptoms emerge prior
to age three to consider an autism diagnosis (American Psychiatric Association, 2000). This
selection was also based on Hatton et al. (2006) finding that children with FXS, including a
portion of participants in our current sample, show subtle but stable increases in CARS
scores over time (approximately .20 points per year). To account for the variability in
outcome ages, chronological age at outcome was included as a covariate in all analyses.
Outcome data were collected either concurrently or shortly following their final assessment
of parent-reported temperament. We treated CARS scores as a continuous variable for
several reasons. First, research supports measuring autism as a continuous array of
symptoms (see Constantino 2011, for review). Second, we were interested in examining the
full spectrum of autistic behavior in FXS rather than categorical distinctions. Finally,
quantifying autism as continuous permits powerful statistical modeling and reveals more
specific information about range of functioning (Constantino 2011; Yoder et al. 2009).
Anxiety—The Child Behavior Checklist (CBCL/1.5–5, 6–18; Achenbach 1991; Achenbach
and Rescorla 2001) is a widely-used parent report scale of internalizing and externalizing
symptoms. Two separate forms are used for children ages 1.5–5 and 6–18 years. The CBCL
has been normed on a large sample and demonstrates high test-retest reliability (r=0.95). The
measure is organized into syndrome-specific scales, broad composite scales, and DSM-
based symptoms scales. Raw scores are converted into T-scores, which may fall in the
average range (≤65), borderline clinical range (66–69), and clinically significant range (70+)
for the syndrome-specific and DSM scales. The CBCL has been widely used with children
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with disabilities including autism (Bolte et al. 1999), FXS (Bargagna et al. 2002; Hatton et
al. 2002; Kau et al. 2004), Prader Willi Syndrome (Dykens and Kasari 1997; van Lieshout et
al. 1998), and Down syndrome (Bargagna et al. 2002; Dykens and Kasari 1997).
The focus of the present study is on the DSM-Anxiety subscale of the CBCL, which consists
of six of the eight CBCL anxiety/depression syndrome scale items that are consistent with
DSM anxiety disorder criteria (Achenbach et al. 2003). This subscale is present on both
forms of the CBCL (ages 1.5–5, 6–18). The DSM subscales of the CBCL/6–18 have shown
similar reliability, convergent validity, and discriminative validity as the broad symptom
scales of the CBCL (Nakamura et al. 2009). Compared to the broader depression/anxiety
scale of the CBCL, the DSM-anxiety subscale specifically targets anxiety symptoms and has
demonstrated higher correspondence with anxiety disorder diagnoses made through
structured clinical interviews (Ebesutani et al. 2010). Many of the studies using the CBCL in
FXS were conducted or published prior to the addition of the DSM subscales of the CBCL
in 2003. However, all of the items on the DSM-Anxiety subscale are from the same item
pool used in the anxiety/depression syndrome scale, which has been extensively used in
FXS (e.g. Hatton et al. 2002; Kau et al. 2004). We selected the earliest CBCL score after 35
months of age to parallel our selection of the autism outcome measure. The average T-score
for our sample is 56.08 (average age of 58.43 months). Notably, we followed publisher
recommendation to use raw scores in research, as the CBCL syndrome and DSM-scale T-
scores are truncated at 50 (Achenbach 1991). The average CBCL raw score in our sample is
3.80 (SD 2.66, range 0–10).
Developmental Age—The Mullen Scales of Early Learning (MSEL; Mullen 1995) is an
individually-administered standardized assessment of developmental abilities for children
ages 0–68 months. The MSEL has been used to assess children a wide range of abilities,
including children with FXS (e.g. Roberts et al. 2009a, b; Zingerevich et al. 2009) and
autism (e.g. Akshoomoff 2006; Munson et al. 2008). The five MSEL domains include gross
motor, fine motor, visual reception, receptive language, and expressive language; which are
reported using T-scores and age equivalents. We calculated total age equivalents by
averaging mental age across four MSEL domains, excluding gross motor. In light of the
previous literature suggesting relationships between mental age and autistic symptoms (Kau
et al. 2004; Roberts et al. 2009a, b; Rogers et al. 2001) and strong correlation between
MSEL and CARS scores in our sample (Pearson r (89)=−0.79, p<0.001, controlling age), we
covaried each participant’s total MSEL age equivalent at outcome. To ensure that
correlations between chronological and mental age did not significantly affect results, we
preliminarily ran each temperament model with one age variable (chronological or mental).
Results were relatively consistent across models, thus we included both chronological and
mental age in the final models.
Results
Data were analyzed using multilevel modeling (MLM) in SAS 9.2 PROC MIXED. MLM
enables simultaneous analysis of within- and between-subject variance (Singer 1998),
providing a powerful method for conceptualizing individualized change over time
(Raudenbush and Bryk 2002). Unlike other longitudinal modeling procedures, MLM
accommodates data in which the timing and frequency of assessments varies across
participants. This feature is particularly important for our sample, as participants entered our
studies at various ages and completed different numbers of assessments.
We characterized the level and change for each component of negative affect (fear,
approach, soothability, sadness, anger) by estimating the unconditional means and growth
for each temperament factor. Based on our relatively small sample and visual inspection of
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empirical growth plots, we only estimated linear growth in MLM. Next, we estimated fixed
effects to test how (1) anxiety and (2) autistic outcomes related to the initial level and
change in parent-reported temperament over time. To include outcome measures within the
multilevel framework, we treated anxiety and autistic symptoms as time-invariant predictors
of levels and change in negative affect.
Data were screened for non-normality, outliers, and heteroskedasticity. We examined
empirical growth plots to confirm the general linear form of data. Q–Q plots indicated
residuals were generally normally distributed both within-and between-subjects, although
the variability at extreme levels of negative affect was slightly lower than at moderate levels.
Patterns of residuals and estimates across individuals suggested outliers were not
substantially affecting the data. Standardized plots suggested equal variances of residuals
across ages. Covariance matrices between observations were set as unstructured, and age
was centered at zero. Table 2 lists partial correlations between predictors and outcomes,
collapsing across observations. Controlling for developmental age, autistic and anxiety
symptoms did not significantly correlate, r(22)=−0.28, p=.19, supporting examination of
these predictors in separate models, particularly given our small sample. We confirmed this
decision by also running less powerful combined models (autism and anxiety in same
model), which presented similar estimates and are therefore not reported.
Unconditional means and growth models estimated level and change in negative affect over
time
(1)
Yij refers to the dependent variable (e.g. fear) of observation i within individual j. β0j and β1j
represent the true change trajectory intercept and slope, respectively, of individual j. eij
represents random error for prediction of the unconditional model. Table 3 includes
parameter estimates, variance components, and fit indices of unconditional means and
growth models. Intercepts significantly differed from zero across the sample. Mean levels of
approach, sadness, and anger increased over time; soothability decreased over time; and fear
did not change over time. Notably, non-clinical samples have shown similar patterns of
change in these temperament dimensions across ages 18–36 months, with the exception of
fear increasing over time (Putnam et al. 2006).
To test our hypothesis that problem behavior outcomes would be predicted by both mean
level and increased negative affect over time, we fit separate MLM to test the effect of each
outcome (level 2 time-invariant explanatory variables) on mean level and change in each
component of parent-reported negative affect.
(2)
(3)
Equation 2 predicts overall level of negative affect (intercept coefficient β0j) from problem
behavior outcomes (Zj). Equation 3 predicts the relationship between negative affect and
age, expressed as the slope coefficient β1j, from problem behavior outcomes (Zj). g00 and u0j
represent the fixed and random effects of time-invariant Level 2 predictors (e.g. autism,
autism x age) and covariates (chronological and mental age at outcome) on the intercept of
negative affect (β0j). g10 and u0i represent fixed and random effects of Level 2 predictors on
the slope, (β1j).
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Contrary to our hypothesis, autism outcomes did not relate to the level or slope of any
negative affect dimension over time (p’s>0.05). Fixed effects estimates indicated anxiety
outcomes significantly relate to mean level of fear, g00=0.14 (0.05), p<0.009; soothability,
g00=−0.10 (0.04), p=0.01; and sadness, g00=0.08 (0.04), p=0.055. Anxiety outcomes also
significantly related to change in approach over time, g01= 0.004 (0.002), p=0.052. Change
over time in sadness and mean levels of anger approached a relationship with anxiety
outcomes (Fig. 1). Fixed effects and variance components are listed in Table 4.
To estimate the proportion of variance in the unconditional models explained by anxiety
outcomes, we calculated pseudo R2 values using procedures outlined by Singer and Willett
(2003, p. 103–4):
Within intercept models, anxiety accounted for approximately 41 % of the variability in fear,
35 % of variability in soothability, 72 % of variability in sadness, and 67 % of variability in
approach change over time. Notably, although pseudo R2 provides a standard method for
estimating relative proportions of variance explained by predictors within a common
trajectory model, the statistic is influenced by both between and within-subject variability
and thus should be interpreted with caution (Singer & Willett).
Power Analysis
To determine whether null effects of CARS outcomes on temperament trajectories related to
underpowered models, we conducted a post hoc Monte Carlo power simulation using Mplus
6.11 software (Muthén and Muthén 2010). For each model, we used covariance and
parameter estimates from our sample to calculate slope coefficients that could be significant
at p=0.05 with 80 % power. For every 1 unit change in CARS scores, our sample was
powered to detect annual corresponding change of 0.02 units of negative affect (range of
Rothbart Scales is 1–7). In our sample, the standard deviation (SD) of negative affect scores
ranges from 0.90 to 1.03, and the SD of CARS scores is 4.93. Thus, our sample is powered
to detect annual rates of change of approximately .10 SD of negative affect per 1 SD of
CARS. Given our sample is adequately powered to detect these modest effects, we can
assume the null relationship between early negative affect and later autistic symptoms does
not result from lack of power.
Discussion
The present study employed multilevel modeling to investigate whether trajectories of early
negative affect predict anxiety and autistic outcomes in young males with FXS. Our results
indicate that higher mean levels of fear and sadness, lower levels of soothability, and
increasing levels of approach over time predicted anxiety, not autism. These data suggest
that early negative affect is an important trait to increase our understanding of the
emergence and prediction of problem behavior in FXS. However, our findings also confirm
the complexity of these relationships, warranting future examination of the multifaceted
factors related to negative affect and problem behaviors in FXS.
Anxiety
Our results replicate the well-documented relationships between behavioral inhibition, a
construct closely linked to negative affect, and anxiety outcomes in typically developing
populations (e.g. Kagan et al. 1987). With the exception of fear, the general patterns of age-
related negative affect change in our sample were similar to trends reported in non-clinical
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samples (e.g. Putnam et al. 2006). Our results also mirror specific work implicating fear
(Gartstein et al. 2010) and soothability (Grant et al. 2009) in anxiety and withdrawal
outcomes in non-clinical samples. Although elevated mean levels of negative affect in our
sample are consistent with findings linking negative affect and anxiety in typical populations
(Gartstein et al. 2010), we did not replicate findings that increasing levels of negative affect
over time also predict anxiety (Gartstein et al. 2010). This inconsistency may reflect the
narrow and young age range of our sample; the median age of onset for most anxiety
disorders in the general population is in middle childhood or adolescence (Kessler et al.
2007), and the average age of outcome assessment in our sample is 4.8 years (range 2.9–
6.0). Thus, our findings supported our hypothesis that early negative affect relates to anxiety
outcomes in FXS; however, this relationship is isolated to mean levels rather than change
over time.
Our study also produced several unexpected findings, including a null relationship between
early anger and anxiety outcomes. This finding lends support to theories that early anger is
more closely related to externalizing traits (Cole et al. 1994; Eisenberg et al. 2001), with
atypical physiological responses potentially moderating this relationship (Putnam et al.
2008). Dysregulated arousal is well-documented in children with FXS (Hall et al. 2006,
2009; Roberts et al. 2001, 2006, 2009a, b). In light of this physiological vulnerability within
FXS, future research may investigate whether externalizing behaviors in FXS, rather than
internalizing symptoms, link to early anger in young children with FXS.
Although we expected to find a relationship between anxiety outcomes and longitudinal
increases in negative affect, we instead found a relationship between anxiety and increased
approach, a construct sometimes classified under the extraversion domain of temperament
(e.g. Putnam et al. 2008). This effect may relate to several facets of the FXS phenotype.
Children with FXS show increases in approach behaviors as familiarity with a communicant
increases (e.g. Hall et al. 2009; Roberts et al. 2007). More specifically, increased
engagement in environmental activities may be paralleled by amplified sensitivity to social
cues and influences, which may pose particular challenges in FXS due to difficulties
physiologically modulating arousal in stressful situations (e.g., Roberts et al. 2001, 2006). In
older children, deficits in cognitive flexibility and executive function inherent to the FXS
phenotype (e.g. Hooper et al. 2008) may further aggravate this system. Thus, a child with
FXS who struggles to self-regulate yet shows high levels of environmental engagement may
actually be more vulnerable to anxiety than a child who displays lower approach. Further
work is needed to test this speculation.
Autism
Although no published studies have prospectively examined the relationship between autism
and temperament in FXS, our results are incongruent with previous research linking
negative affect to autism in infant siblings of children with autism (Bryson et al. 2007;
Garon et al. 2009; Watson et al. 2007; Zwaigenbaum et al. 2005), as well as emerging work
suggesting early atypical self-modulation in FXS relates to later autistic symptoms (Roberts
et al. 2012). This inconsistency may reflect overlapping phenotypic features of autism and
FXS phenotype, such as withdrawal and social anxiety, which may be difficult to tease apart
using non-diagnostic rating-scale measures. Our findings may also indicate that negative
affect operates as an etiologically specific identifier in infant siblings that does not apply to
children with FXS. This possibility is consistent with findings of distinct neural profiles in
young children with idiopathic autism compared to children with FXS+autism (Hazlett et al.
2009). Understanding the unique predictors of autism across etiological groups is essential
to accurate and early identification of the disorder.
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In summary, our findings suggest a specific relationship between negative affect and
anxiety, not autism, within FXS. To further understand this relationship, future research may
explore outcomes specific to children with FXS+autism, such as persistent deficits in social
approach (Roberts et al. 2007), to better elucidate autism precursors from global measures of
autism and withdrawal symptoms. Similarly, investigating underlying physiological or
neurocognitive processes associated with autism may be essential to distinguishing between
comparable observable behaviors that may be rooted in distinct neurocognitive processes.
For example, failure to improve gaze over time, a behavior specifically associated with FXS
+autism (Roberts et al. 2007, 2009a, b), may reflect core socio-communicative deficits
specific to autism, rather than withdrawal-related features common to FXS (see Volkmar
2011, for review of relevant autism symptoms). These possibilities warrant syndrome-
sensitive examination of neurobiological components of anxiety and temperament, such as
physiological arousal and attention (Barlow 2000), to more thoroughly elucidate the
relationship among negative affect, anxiety, autism, and FXS.
Limitations and Future Directions
Despite our novel findings linking negative affect to anxiety in FXS, our study faces several
limitations. Although the CARS is an empirically validated and reliable screening tool for
autism, future work may use gold standard diagnostic tools such as the Autism Diagnostic
Observation Scale (ADOS; Lord et al. 1989) to permit more fine-grained examination of
these relationships. Similarly, we used a single anxiety subscale, which may provide limited
information about the broad range of anxiety symptoms in our sample. Our reliance on
parent-report measures of negative affect and anxiety may also reflect the subjective
experience of parents and thus may be inconsistent with experimental assessments
administered by clinicians. However, Shanahan et al. (2008) demonstrated general
concordance between experimental and parent-report measures of childhood temperament in
FXS, supporting the general validity of parent-reported temperament in this population.
Supplementing parent-report measures in FXS may be particularly important in light of the
high rates of depression and anxiety in mothers of children with FXS (Bailey et al. 2008a;
Roberts et al. 2009a) and the association between maternal psycho-pathology and biased
report of child behaviors (Weis and Lovejoy 2002). Furthermore, differential relationships
between negative affect and our outcome measures may relate, in part, to rater variance, as
parents and experimenters may report different perceptions of behavior. As such, future
studies should investigate the relationship between negative affect and anxiety using multi-
method, multi-informant measurement.
Future work may also explore the genetic and environmental vulnerabilities that contribute
to anxiety outcomes in FXS. Maternal sensitivity and parenting style have been identified as
moderators of the fear-anxiety relationship (Gartstein et al. 2010; Kiel and Buss 2009),
which may be particularly important in FXS due to the high parenting stress associated with
raising a child with FXS (e.g. Bailey et al. 2008b) and elevated rates of psychopathology in
women with the FMR1 premutation (e.g. Bailey et al. 2008a). A substantial body of
literature has linked parenting stress and depression to early negative affect and anxiety in
children (e.g. Gartstein et al. 2010; Hudson and Rapee 2001, 2002), suggesting children with
FXS may face particularly elevated risks due to both temperamental and environmental
factors. Despite this dual vulnerability of child and family factors, no studies have
specifically investigated how maternal symptoms relate to the negative affect in this sample.
Increased attention to these early risk factors is essential to intervening on and minimizing
the potential negative effects of chronic hyperarousal and anxiety, particularly during early
developmental periods of neural plasticity (Duke 2008).
The current study presents the first prospective examination of negative affect as a predictor
of anxiety and autistic outcomes in high-risk children with FXS. Understanding early
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predictors of psychopathology in FXS is particularly important given the extremely elevated
rates of anxiety disorders and autism in this clinical population. In addition to endorsing
temperament as a relevant predictor of anxiety outcomes in FXS, our work provides a
foundation for future studies that may explore the early neurobiological and environmental
processes related to anxiety and autistic outcomes in this population. This work is
particularly important given the empirical void in early intervention FXS literature (see Hall
2009, for review). In addition to informing early characterization and treatment of anxiety in
FXS, our findings may also inform theoretical models of anxiety disorders in general, thus
potentially informing etiology and treatment in non-FXS samples.
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Individual linear temperament trajectories across age, separated by level of anxiety at
outcome. Participants are grouped by CBCL DSM-Anxiety t-score into Low (<60) or High
(≥60) groups for display purposes only. Results indicate significant relationship between
anxiety and level of fear, sadness, and soothability; as well as increasing approach over time
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Table 1
Descriptive statistics
M SD Min Max
Age of first assessment 15.16 6.88 8 35
Age across all assessments 31.91 18.20 8 71
Number of assessments 4.16 1.60 2 7
Time in study (in months) 40.16 14.38 6 61
CARS total score 27.48 4.93 18 40
CBCL DSM-Anxiety raw score 3.80 2.66 0 10
CBCL DSM-Anxiety t-score 56.08 7.47 50 75
Age at CARS and CBCL 58.43 10.71 35 72
Age reported in months. CARS childhood autism rating scale. CBCL childhood behavior checklist. “Assessments” refer to sessions in which
parent-reported temperament and mental age were measured. CARS and CBCL data were collected either concurrently or shortly following the
final assessment of parent-reported negative affect
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